GILLA KAPLAN

CIK 1247024 · last filed 2026-06-04

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$1.19M

Companies

5

Total Filings

75

Lifetime Open-Market Net

-$44.27M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
AVTX Director 3,167 $14.76 $46.7K $0 11 2026-06-04
TYRA Director 42,526 $26.99 $1.15M -$1.16M 8 2026-03-27
Avalo Therapeutics, Inc. (CERC) Delisted Director $2.93 $0 5 2021-07-02
CELGENE CORP /DE/ (CELGZ) Delisted Director 121,837 -$36.57M 39 2018-05-21
CELGENE CORP /DE/ (CELG) Delisted Director 685 -$6.54M 12 2010-06-18

Recent Filings · Page 2 of 8

75 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2023-12-21 AVTX Grant (A) $0 EDGAR
2023-06-02 TYRA Grant (A) $0 EDGAR
2022-10-03 AVTX Grant (A) $0 EDGAR
2022-07-01 AVTX Grant (A) $0 EDGAR
2022-06-15 AVTX Grant (A) $0 EDGAR
2022-06-15 TYRA Grant (A) $0 EDGAR
2022-04-04 AVTX Grant (A) $0 EDGAR
2022-01-04 AVTX Grant (A) $0 EDGAR
2021-10-04 AVTX Grant (A) $0 EDGAR
2021-07-02 Avalo Therapeutics, Inc. (CERC) Delisted Grant (A) $0 EDGAR
Showing 1120 of 75
Page 2 of 8
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.